Stock Price Quote

IND-SWIFT LABORATORIES LTD.

NSE : INDSWFTLABBSE : 532305ISIN CODE : INE915B01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE61.201.3 (+2.17 %)
PREV CLOSE ( ) 59.90
OPEN PRICE ( ) 61.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4125
TODAY'S LOW / HIGH ( )60.80 62.00
52 WK LOW / HIGH ( )55.6 127.35
NSE61.351.5 (+2.51 %)
PREV CLOSE( ) 59.85
OPEN PRICE ( ) 61.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13223
TODAY'S LOW / HIGH( ) 60.60 61.90
52 WK LOW / HIGH ( )55.05 127.45
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 04-01 1995
Management Info
N R Munjal - Chairman N R Munjal - Managing Director
Registered Office

Address S C O 850,Shivalik Enclave, N A C,Manimajra,
Chandigarh,
Punjab-160101

Phone 0172 5061850, 2730920

Email investor@indswiftlabs.com

Website www.indswiftlabs.com

Registrars Details
Alankit Assignments Ltd.
205-208 , Anarkali Complex,Jhandewala Extension,,New Delhi
Listing : BSE, NSE, MCX

NEWS

22Apr Ind-Swift Laboratories informs about c
In compliance with Regulation 74(5) of SEBI (Depositories arid Participa..
22Sep Ind-Swift Laboratories informs about d
In terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015..
31Jul Ind-Swift Laboratories informs about o
Ind-Swift Laboratories has informed that the Board of Directors of the C..
16Jul Ind-Swift Laboratories informs about d
Ind-Swift Laboratories has informed that in terms of the SEBI (Prohibiti..
08Jun Ind-Swift Laboratories informs about a
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure R..

Financials

in Millions
QTR Dec 21 ANNUAL 21
Net Profit148.73-44
Gross Profit 148.73 161.16
Operating Profit 615.552036.24
Net Sales 2402.978565.78

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddy's Lab (BSE)
peergroup  4246.30 (8.10%)
M.Cap ( in Cr)70669.41
Divi's Lab (BSE)
peergroup  4306.60 (2.53%)
M.Cap ( in Cr)114326.70
Pfizer (BSE)
peergroup  4352.00 (2.06%)
M.Cap ( in Cr)19909.41
Alkem Laboratories (BSE)
peergroup  3001.30 (2.87%)
M.Cap ( in Cr)35885.04
Torrent Pharma (BSE)
peergroup  2664.45 (2.82%)
M.Cap ( in Cr)45084.82

Shareholding Pattern

PROMOTERS 42%
NON-INSTITUTION 38.44%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Ind-Swift Laboratories Ltd.

Ind-Swift Laboratories Ltd. was incorporated in the year 1995. Its today's share price is 61.2. Its current market capitalisation stands at Rs 361.61 Cr. In the latest quarter, company has reported Gross Sales of Rs. 8633.91 Cr and Total Income of Rs.8797.06 Cr. The company's management includes Pardeep Verma, Rajinder Kumar Gupta, Ashwani K Vig, Neerja Chathley, S P Sharma, Sahil Munjal, Rishav Mehta, Himanshu jain, N R Munjal, N R Munjal.

It is listed on the BSE with a BSE Code of 532305 , NSE with an NSE Symbol of INDSWFTLAB and ISIN of INE915B01019. It's Registered office is at S C O 850,Shivalik Enclave, N A C,ManimajraChandigarh-160101, Punjab. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Avishkar Singhal & Associates, Jain & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)